Innovative non-invasive biotechnology for Deep Metabolism Assessment (DMA) and early diagnosis

brand-new technology enabling a precise patient's health assessment and personalized treatments

application to Sports Medicine and nutrition

More than

sets of measures acquired during the past years show:

A significant coherence with diagnoses based on traditional diagnostic exams.

A decisive contribution of the person's Metabolic profile to the diagnosis and the care.

Multiple clinical areas benefit from the Deep Metabolism Assessment (DMA)

Here are some examples:

R

Endocrinology

R

autoimmune deseases

R

study of neurodegenerative diseases

R

alterations of the digestive system

R

classification of childhood obesity

R

alterations of the cardiorespiratory system

R

alterations of the cardiocirculatory system

R

Oncology (tumors detection)

R

Sport Medicine

R

nutrition,
intolerances & allergies

R

metabolic impact on genetic mutations

R

Viral, Mycotic, Bacterial, Parasitic infections

are you
Clinical Research Center or Hospital?

If you are a Clinical Research Center or Hospital interested in
the metabolic profiling as an instrument to support diagnosis and care, do not hesitate to contact us.

are you an
Investor?

Are you an Investor?
We are developing the business, and we are now planning a multi-stage investment program. So if you are interested in our initiative, do not hesitate to contact us here.

are you
an Researcher or Research Institute?

Are you a researcher or a Research Institute?
If you want to join us or cooperate on a research project, do not hesitate to contact us here…

are you

an Industrial Company?

Are you an industrial company in the health, pharma or life science sector?
We are open to evaluating opportunities.

News

August 2022 
Certification process of the DMA Industrial Edition 1 started !!

June 2022
Design of the industrial version of the DMA bio-sensor completed.

May 2022 
Successfully completed the test of the biosensors and the electronic devices 3.0

April 2022
IT infrastructure design completed. The IT cloud-to-edge infrastructure permits the management of data streams from several DMA biosensors safel

February 2022 
Successfully completed the test of the biosensors and the electronic devices 2.0.

January 2022 
Start a new Phd research plan at the department of Mathematics of the University the Salerno University.

December 2021 
Capital investment for 3200.000 € finalized.

November 2021 
Deep Metabolism Assessment DMA bio-sensor prototype 00.00 tested with positive results.

October 2021 
Math Biology present at SMAU as a partner of the Cluster  TAV Tech for life.

October 2021 
The first edition of our website goes online.

Sept 2021 
R&D activities stage 1 completed to produce the first DAM bio-sensor prototype.

May 2021 
MISTER, CNR Consortium  join the Math Biology empowering Math Biology R&D and design capabilities.